COVID-19 recovered people showing faster antibody response to Covishield vaccine
India
Updated: Wednesday, March 3, 2021, 17:47 [IST]
New Delhi, Mar 03: Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India s corona immunisation cover.
Representational Image
The study on the immune response to Covishield was carried out by researchers from New Delhi s CSIR-Institute of Genomics and Integrative Biology (IGIB), Max Super Speciality Hospital and Institute of Endocrinology, Diabetes and Metabolism as well as the Academy of Scientific and Innovative Research (AcSIR) in Ghaziabad.
Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Updated Feb 08, 2021 | 12:30 IST
She was admitted to the hospital when she complained of post-menopausal bleeding. She also had co-morbidities such as obstructive sleep apnea, high blood pressure, mood disorder, depression, among others. Doctors successfully treat woman with endometrial cancer, weighing 142 kg | Photo Credit: iStock Images
New Delhi: A woman suffering and diagnosed with endometrial cancer, and weighing 142 kg, has recently been treated at a Delhi hospital for the deadly disease. According to a press release, she was admitted to the hospital when she complained of post-menopausal bleeding. She also had co-morbidities such as obstructive sleep apnea, high blood pressure, mood disorder, depression, and mild anxiety disorder. After being investigated with PET-CT, it was discovered that there is a mass in her uterus, which could be cancer.
URL copied Image Source : PTI
New Delhi: Delhi Chief Minister Arvind Kejriwal chairs a review meeting of the preparations made for the Delhi Govt s COVID vaccination rollout plan, in New Delhi.
Authorities at various facilities have said Delhi hospitals are trained to address situations arising out of any adverse effects following the administration of the COVID-19 vaccine dose. The vaccination roll-out is set to begin from Saturday across the country, and 81 sites in Delhi have been chosen for the exercise. These centres, with nearly an even split of government and private hospitals, include six central government facilities - AIIMS, Safdarjung Hospital, RML Hospital, Kalawati Saran Children Hospital and two ESI hospitals.